Bit player or powerhouse? China and stem-cell research.

@article{Murray2006BitPO,
  title={Bit player or powerhouse? China and stem-cell research.},
  author={Fiona E. Murray and Debora Spar},
  journal={The New England journal of medicine},
  year={2006},
  volume={355 12},
  pages={
          1191-4
        }
}
Fiona Murray and Debora Spar discuss whether, in research on embryonic stem cells, for which the U.S. government currently severely restricts federal funding, China could surpass the United States in either research or commercial development. 
View on PubMed
fmurray.scripts.mit.edu
23 Citations
Background Citations
5

23 Citations

Citation Type

Citation Type

Stem cell science on the rise in China.
Stem Cell Research Policies around the World
The proliferation of stem cell research, conflated with its ethical and moral implications, has led governments to attempt regulation of both the science and funding of stem cells. Due to a diversity…
Stem cell research in China
TLDR
China has the most liberal and favourable environments for human embryonic stem cell research and clinical applications of stem cells in the treatment of acute heart failure, acute liver failure and lower limb ischaemia have been reported by many hospitals.
Characterizing International Stem Cell Research Niches
Regenerative medicine has evolved differently in global regions, in part due to policies and funding patterns but also due to their styles of governance within particular historical and political…
Fundamentals of the Stem Cell Debate
TLDR
This analysis follows an excellent essay by Philip Nickel, who wrestles with what criteria are needed to define a person and give him “moral standing” and what should be done when disparate views collide in the public arena.
United States stem cells research boundaries
TLDR
The boundaries that have emerged in the US in this particular field are examined and their impact on the US market of fertilized eggs, embryos and human embryonic stem cells are tried to understand.
State performance in pluripotent and adult stem cell research, 2009-2016.
TLDR
It is suggested that permissive state stem cell policy may be one of the several factors contributing to strong state performance in pluripotent stem cell research.
Scientific institutions and effective governance: a case study of Chinese stem cell research
  • J. Zhang
  • Business
    New genetics and society
  • 2011
TLDR
It is demonstrated that despite China's recent efforts to attract highly competent researchers and to launch new regulatory initiatives, the effects of these attempts have been diminished by an absence of middle-layer positions within research teams and by the uncoordinated administrative structures among regulatory bodies.
Science policy and the geographic preferences of stem cell scientists: understanding the appeal of China and Singapore
As scientific advances increasingly pose ethical questions, policymakers must decide how, if at all, to integrate controversial lines of inquiry into existing national innovation systems. This study…
Biotech Pilgrims and the Transnational Quest for Stem Cell Cures
  • P. Song
  • Medicine
    Medical anthropology
  • 2010
TLDR
Critiquing popular notions of “medical tourism,” the alternative concept of "biotech pilgrimage" is developed to reveal how faith intertwines with technology, travel, and the political economies of health care and medical research in a global era.
...
1
2
3
...